PDCD1 and colon carcinoma: Kurtulus et al. [100] studied PD-1− CD8+ T cells from mice bearing colon carcinoma and observed a reduction in naïve-like cells along with the expansion of memory-precursor- and effector-like cells after anti-PD-1 and anti-TIM-3 blockade.